MYGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MYGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).
Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.
Myriad Genetics's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.
For the Diagnostics & Research subindustry, Myriad Genetics's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Myriad Genetics's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:
* The bar in red indicates where Myriad Genetics's Margin of Safety % (DCF Dividends Based) falls into.
Thank you for viewing the detailed overview of Myriad Genetics's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.
Paul J Diaz | director, officer: President and CEO | 680 SOUTH FOURTH STREET, LOUISVILLE KY 40202 |
Dale Muzzey | officer: Chief Scientific Officer | 322 NORTH 2200 WEST, SALT LAKE CITY UT 84116 |
Heinrich Dreismann | director | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Reitan Colleen F | director | 300 THIRD STREET, CAMBRIDGE MA 02142 |
Margaret Ancona | officer: SVP, Chief of Staff | 322 NORTH 2200 WEST, SALT LAKE CITY UT 84116 |
Rashmi Kumar | director | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Daniel K Spiegelman | director | MYRIAD GENETICS, 320 WAKARA WAY, SALT LAKE CITY UT 84003 |
Lee Nisley Newcomer | director | 264 BUSHAWAY ROAD, WAYZATA MN 55391-1901 |
Richard Bryan Riggsbee | officer: Chief Financial Officer | 322 NORTH 2200 WEST, SALT LAKE CITY UT 84116 |
Nicole Lambert | officer: Chief Operating Officer | 322 NORTH 2200 WEST, SALT LAKE CITY UT 84116 |
Pamela Wong | officer: Chief Legal Officer | 322 NORTH 2200 WEST, SALT LAKE CITY UT 84116 |
Shereen Solaiman | officer: Chief People Officer | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Paul Bisaro | director | |
Kevin Richard Haas | officer: Chief Technology Officer | 322 NORTH 2200 WEST, SALT LAKE CITY UT 84116 |
Natalie Munk | officer: Chief Accounting Officer | 322 NORTH 2200 WEST, SALT LAKE CITY UT 84116 |
From GuruFocus
By GuruFocus Research • 09-05-2024
By Marketwired • 06-03-2024
By Marketwired • 08-01-2024
By Marketwired • 06-24-2024
By GuruFocus Research • 08-07-2024
By Marketwired • 09-18-2024
By Marketwired • 07-17-2024
By GuruFocus Research • 08-07-2024
By GuruFocus Research • 09-13-2024
By GuruFocus Research • 09-11-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.